Cholesterol Self-testing in Patients Post Acute Coronary Syndrome

Launched by UNIVERSITY OF LEIPZIG · Jul 23, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new way to help patients who have recently experienced an acute coronary syndrome (like a heart attack) lower their cholesterol levels more effectively. High levels of LDL cholesterol, often referred to as "bad" cholesterol, can increase the risk of heart problems, and many patients struggle to reach the desired cholesterol levels despite taking medications. The goal of the study is to see if self-testing for cholesterol can help these patients achieve their target levels faster and improve their overall heart health.

To participate in this trial, you need to be at least 18 years old and have had an acute coronary syndrome event in the past six months without reaching the recommended cholesterol levels. You will need to provide consent to join and be willing to perform self-measurements of your cholesterol. However, if you are unable to understand the study, unwilling to take additional cholesterol-lowering medications, or are a pre-menopausal woman without proper contraception, you may not be eligible. If you join the study, you can expect to learn more about your cholesterol levels and how to manage them better, with the aim of reducing the risk of future heart problems.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age ≥ 18 years
• • Patients with acute coronary syndrome in the last 6 months and not having reached the LDL target value
• • Signed informed consent
• Exclusion Criteria:
• • Persons unable to understand the study
• • Persons unable or unwilling to perform self-measurements
• • Persons unable or unwilling to undergo additional cholesterol-lowering therapy to reach the LDL target
• • Pre-menopausal women without contraception
• • Use of experimental drugs or investigational products within 30 days prior to screening
• • Employees or contractors of the institution conducting the study or family members of the Principal Investigator, Co-Investigator, or financial supporter